GUERNSEY, Channel Islands (BUSINESS WIRE), July 07, 2010 - Conversus Capital, L.P. (Euronext Amsterdam: CCAP) (“Conversus”), today announced that it has engaged Amsterdam's Effectenkantoor B.V. (“AEK”) to act as a Liquidity Provider to render brokerage services with respect to Conversus’ common units listed on Euronext Amsterdam by NYSE Euronext (“Euronext”).
Under the Engagement and subject to its terms, AEK will act as a Liquidity Provider for Conversus whereby it will issue a continuous quote in the order book, in compliance with the applicable provisions of the Euronext Rule Books.
“We remain focused on increasing the liquidity of Conversus’ units,” said Tim Smith, Chief Financial Officer, Conversus Capital, L.P. “As a liquidity provider to over 20 institutions on Euronext, AEK has great experience with and knowledge of Euronext trading processes. We are confident AEK will complement our existing strategic relationships and will contribute significantly to our goal of ensuring an efficient market for the trading of our units.”
AEK’s engagement as Liquidity Provider is in addition to Conversus’ existing Liquidity Provider agreement with Royal Bank of Scotland which remains in effect.
About Conversus Capital
Conversus Capital, L.P. (Euronext Amsterdam: CCAP) (“Conversus”) is a permanent capital vehicle and the largest publicly traded portfolio of third party private equity funds. Conversus’ objective is to provide unit holders with immediate exposure to a diversified portfolio of private equity assets, access to best-in-class general partners and consistent NAV growth that outperforms the public markets. Conversus Asset Management, LLC (“CAM”), an independent asset manager, implements Conversus’ investment policies and carries out the day to day operations of Conversus pursuant to a services agreement. CAM leverages the platforms of Bank of America and Oak Hill, its primary owners.
Legal Disclaimer
These materials are not an offer to sell, or a solicitation of an offer to buy, securities in the United States or elsewhere. Securities may not be sold in the United States absent registration with the U.S. Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended. Conversus is not a registered investment company under the U.S. Investment Company Act of 1940, as amended (the “Investment Company Act”), and the resale of Conversus securities in the United States or to U.S. persons other than to qualified purchasers as defined in the Investment Company Act is prohibited. Conversus does not intend to register any offering in the United States or to conduct a public offering of its securities in the United States. Past performance is not necessarily indicative of future results.
The common units and related restricted depositary units of Conversus are subject to a number of ownership and transfer restrictions. Information concerning these ownership and transfer restrictions is included in the Investor Relations section of Conversus’ website at www.conversus.com.